From 1990 to 2019, the absolute number of incident strokes increased by 70♰% (67♰–73♰), prevalent strokes increased by 85♰% (83♰–88♰), deaths from stroke increased by 43♰% (31♰–55♰), and DALYs due to stroke increased by 32♰% (22♰–42♰). Globally, stroke remained the second-leading cause of death (11♶% of total deaths) and the third-leading cause of death and disability combined (5♷% of total DALYs) in 2019. In 2019, there were 12♲ million (95% UI 11♰–13♶) incident cases of stroke, 101 million (93♲–111) prevalent cases of stroke, 143 million (133–153) DALYs due to stroke, and 6♵5 million (6♰0–7♰2) deaths from stroke. These estimates were provided for ischaemic stroke, intracerebral haemorrhage, subarachnoid haemorrhage, and all strokes combined, and stratified by sex, age group, and World Bank country income level. We applied GBD 2019 analytical tools to calculate stroke incidence, prevalence, mortality, disability-adjusted life-years (DALYs), and the population attributable fraction (PAF) of DALYs (with corresponding 95% uncertainty intervals ) associated with 19 risk factors, for 204 countries and territories from 1990 to 2019. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) aims to provide a standardised and comprehensive measurement of these metrics at global, regional, and national levels.

Regularly updated data on stroke and its pathological types, including data on their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are important for evidence-based stroke care planning and resource allocation.

Andexanet alfa dosing